Tongjitang Chinese Medicines Company Announces Closing of Merger and Intent to Delist from the NYSE
SHENZHEN, China, April 15, 2011 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company ("Tongjitang" or the "Company"; NYSE: TCM), announced today the completion of its acquisition by Hanmax Investment Limited, a British Virgin Islands business company ("Hanmax"), and Fosun Industrial C...
Tongjitang Chinese Medicines Company Shareholders Vote to Approve Merger
SHENZHEN, China, March 31, 2011 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company ("Tongjitang" or the "Company"; NYSE: TCM), announced today that, at an extraordinary general meeting held today, the Company's shareholders voted in favor of the proposal to adopt the previously disclosed Agre...
Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results
SHENZHEN, China, March 26, 2011 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in ...
Tongjitang Chinese Medicines Company to Announce Fourth Quarter and Full Year 2010 Financial Results
-- Company to Hold Conference Call on March 28, 2011 at 8:00 am ET -- SHENZHEN, China, March 21, 2011 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketi...
Tongjitang Chinese Medicines Company Announces Extraordinary General Meeting of Shareholders
SHENZHEN, China, Feb. 25, 2011 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company ("Tongjitang" or the "Company"; NYSE: TCM), announced that it has called an extraordinary general meeting of shareholders (the "EGM"), to be held at 10:00 a.m. (China time) on Thursday, March 31, 2011, at the Co...
Tongjitang Chinese Medicines Company Reports Third Quarter 2010 Financial Results
SHENZHEN, China, Nov. 30, 2010 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, toda...
Tongjitang Chinese Medicines Company Files Going-Private Transaction Statement on Schedule 13E-3 With US Securities and Exchange Commission
SHENZHEN, China, Nov. 29, 2010 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company ("Tongjitang" or the "Company") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, toda...
Tongjitang Chinese Medicines Company to Announce Third Quarter 2010 Financial Results on November 29, 2010
SHENZHEN, China, Nov. 24, 2010 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company"; NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today annou...
Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited
SHENZHEN, China, Nov. 1, 2010 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company (NYSE: TCM) ("Tongjitang" or the "Company"), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today...
Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement
-- Sale of Non-Core Operating Segment Allows Greater Focus on Core Pharmaceutical Business -- SHENZHEN, China, Sept. 28 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the dev...
Tongjitang Chinese Medicines Company Announces Resignation of CFO, Effective December 2, 2010
SHENZHEN, China, Sept. 8 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in Chi...
Tongjitang Chinese Medicines Company Reports Second Quarter 2010 Financial Results
SHENZHEN, China, Aug. 19 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, ...
Tongjitang Chinese Medicines Company to Announce Second Quarter 2010 Financial Results on August 18, 2010
-- Company to Hold Conference Call on August 19, 2010 at 8:00 am ET -- SHENZHEN, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company"; NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing ...
Tongjitang Files 2009 Annual Report on Form 20-F
SHENZHEN, China, July 1 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company (the "Company"; NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it ...
Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results
- 1Q10 Revenue Increases 25.6% Y-O-Y to RMB 113.3 Million ($16.6 Million) - SHENZHEN, China, June 19 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, ma...
Tongjitang Chinese Medicines Company to Announce First Quarter 2010 Financial Results on June 18, 2010
- Company to Hold Conference Call on June 21, 2010 at 8:00 am ET - SHENZHEN, China, June 15 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, ...
The Independent Committee of the Board of Directors of Tongjitang Appoints Morgan Stanley Asia Limited as Its Financial Advisor
SHENZHEN, China, June 1 /PRNewswire-Asia/ -- The Independent Committee of the Board of Directors of Tongjitang Chinese Medicines Company ("Tongjitang" or the "Company"; NYSE: TCM), comprised of the Company's three independent directors, Dr. Harry K. Genant, Mr. David R. White and Mr. Yongcun Che...
Tongjitang Establishes Special Committee to Evaluate Buyout Proposal
SHENZHEN, China, April 13 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine i...
Tongjitang Receives Proposal to Acquire All Outstanding Shares of the Company
SHENZHEN, China, April 8 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in Chi...
Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2009 Financial Results
- 4Q09 Revenue Increases 31.5% Y-O-Y to RMB 151.5 million ($22.2 million) - SHENZHEN, China, March 31 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturin...
